Molecules 2013, 18
7088
refluxed for 3 h, then allowed to cool to room temperature. The solid product so formed was collected
by filtration and crystallized from acetic acid. Compound 3 was obtained as a light brown powder
(87%), m.p. 226–228 °C; IR (KBr): 3451 (NH), 1706, 1659 (CO) cm-1; 1H-NMR (DMSO-d6): δ = 2.16
(s, 3H, CH3), 2.31 (s, 6H, 2(p-tolyl-CH3)), 7.10–7.40 (m, 4H, p-tolyl-H), 7.46 (d, 2H, J = 8.4 Hz,
p-tolyl-H), 7.52 (d, 2H, J = 7.2 Hz, p-tolyl-H), 8.79 (s, 1H, pyridyl-H). 9.91 (s, 1H, NH). MS, m/z (%),
383 ([M-2]+, 32), UV/Vis at λmax(DMF) = 590. Anal. Calcd. For C22H19N5O2: C, 68.56; H, 4.97; N,
18.17. Found C, 68.58; H, 4.99; N, 18.26.
7-Amino-5-methyl-2-p-tolyl-4-p-tolylazo-2H-thieno[3,4-d]pyridazin-1-one (4).
A
mixture of
compound 1 (3.55 g, 10 mmol) and elemental sulphur (0.32 g, 10 mmol) and a few drops of piperidine
in dioxane (10 mL) was refluxed for 4 h then allowed to cool to room temperature. The crude product
was poured onto water, the solid product, so formed, was collected by filtration and crystallized from
ethanol. Compound 4 was obtained as wine red crystals (89%), m.p. 209 °C (Lit. [12] m.p.
1
208–209 °C), IR (KBr): 3321, 3278 (NH2), 1642 (CO) cm-1; H-NMR (DMSO-d6): δ = 2.30 (s, 3H,
CH3), 2.37 (s, 3H, p-tolyl-CH3), 2.40 (s, 3H, p-tolyl-CH3), 7.21 (d, 2H, J = 10.2 Hz, p-tolyl-H), 7.32
(d, 2H, J = 9.6 Hz, p-tolyl-H), 7.38 (s, 2H, NH2), 7.39 (d, 2H, J = 7.2 Hz, p-tolyl-H), 7.78 (d, 2H,
J = 7.2 Hz, p-tolyl-H). 13C NMR (DMSO-d6): δ = 160.77 (CO), 159.2, 150.4, 150.1, 144.0, 139.5,
136.9, 130.7, 129.5, 126.3, 123.6, 121.9. 116.7, 104.7, 21.5 (p-tolyl-CH3), 21.0 (p-tolyl-CH3), 14.7
(CH3). MS (EI) m/z = 389 (M]+, 100); UV/Vis at λmax(DMF) = 464 nm. Anal. Calcd for C21H19N5OS:
C, 64.76; H, 4.92; N, 17.98; S, 8.23. Found: C, 65.09; H, 5.08; N, 17.90; S, 8.21.
9-Amino-5-methyl-7-phenyl-2-p-tolyl-4-p-tolylazo-2H-pyrrolo[3,4-g]phthalazine-1,6,8-trione (7). A
solution of compound 4 (3.89 g, 10 mmol), N-phenylmaleimide (1.73 g, 10 mmol) and a few drops of
acetic acid was refluxed in dioxane (15 mL) for 10 h. The solid products, so formed, were collected by
filtration and crystallized from DMF. Compound 7 was obtained as orange crystals (79%), m.p.
302–304 °C) (Lit. [12] m.p. 300–302 °C), IR (KBr): 3435, 3310 (NH2),1752, 1704, 1645 (CO) cm−1;
1H-NMR (DMSO-d6): δ = 2.42 (s, 3H, CH3), 2.48 (s, 3H, p-tolyl-CH3), 2.75 (s, 3H, p-tolyl-CH3), 7.36
(d, 2H, J = 7.8 Hz, p-tolyl-H), 7.50 (d, 4H, J = 8.1 Hz, p-tolyl-H), 7.57–7.64 (m, 5H, phenyl-H), 7.94
(d, 2H, J = 7.7 Hz, p-tolyl-H), 9.47 (s, 2H, NH2). MS (EI) m/z = 528 ([M]+, UV/Vis at λmax(DMF) = 471 nm.
Anal. Calcd for C31H24N66O3: C, 70.44; H, 4.58; N, 15.90. Found: C, 69.99; H, 4.58; N, 15.96.
N,N-Dimethyl-N'-(7-methyl-4-oxo-3-p-tolyl-1-p-tolylazo-3,4-dihydrothieno[3,4-d]pyridazin-5-yl)-
formamidine (8). A mixture of compound 4 (3.89 g, 10 mmol) and DMFDMA (1.19 g, 10 mmol) in
dimethylformamide (15 mL), was refluxed for 1 h. The solvent was evaporated and then the residue
was washed with ethanol. The solid product, so formed, was collected by filtration and crystallized
from dimethylformamide. Compound 8 was obtained as wine red crystals (93%), m.p. 307 °C
1
(Lit. [12] m.p. 203–205 °C), IR (KBr): 1651 (CO) cm-1. H-NMR (DMSO-d6): δ = 2.31 (s, 3H, CH3),
2.39 (s, 3H, p-tolyl-CH3), 2.53 (s, 3H, p-tolyl-CH3), 2.96 (s, 3H, N-CH3), 3.04 (s, 3H, N-CH3), 7.22 (d,
2H, J = 9.0 Hz, p-tolyl-H), 7.30 (d, 2H, J = 9.0 Hz, p-tolyl-H), 7.41 (d, 2H, J = 7.8 Hz, p-tolyl-H), 7.80
(d, 2H, J = 8.4 Hz, p-tolyl-H), 7.92 (s, 1H, amidine-H). 13C NMR (DMSO-d6): δ = 163.7 (CO), 157.5,
157.3, 150.5, 149.9, 144.0, 139.2, 137.1, 130.7, 129.3, 126.8, 125.4, 123.8, 123.7, 112.9, 34.7
(N-CH3), 21.5 (p-tolyl-CH3), 21.0 (p-tolyl-CH3), 15.8 (CH3). MS (EI) m/z = 444 (M]+, 100), UV/Vis at